This study was designed to assess the circadian variation of the efficacy of thrombolytic therapy (TT) in 163 patients with acute myocardial infarction. Statistical analysis of the results suggests the existence of circadian variation in the efficacy of thrombolytic therapy with marked early morning resistance and significantly better late daytime results. There is a strong relationship between the normal physiologic rhythms of biochemical, hemodynamic, and hematologic parameters, observed in patients with CAD and the circadian fluctuations of efficacy of TT. Obviously the efficacy of TT is influenced by more evident impact of chronorisk factors during the early morning hours.
Get full access to this article
View all access options for this article.
References
1.
Portaluppi F, Manfredini R, Fersini C: From a static to a dynamic concept of risk: The circadian epidemiology of cardiovascular events. J Biol Med Rhythm Res16-1:33-49, 1999.
2.
Kono T, Morita H, Nishina T, et al: A. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol27:774-778, 1996.
3.
Cohen MC, Rohtala KM, Lavery CE, et al: Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol79-11:1512-1516, 1997.
4.
Aki Z, Imren E, Boyaci B, et al: Circadian variations of unstable angina and acute myocardial infarction. Gazi Med J9:107-111, 1998.
5.
Culic V, Eterovic D, Miric D, et al: Gender differences in triggering of acute myocardial infarction. Am J Cardiol85:753-756, 2000.
6.
Kovak J, Gershlick A: How should we detect and manage failed thrombolysis? Eur Heart J22:450-457, 2001.
7.
Oude Ophuis AJ, Bär FW, Vermeer F, et al: Angiographic assessment of prospectively determined noninvasive reperfusion indices in acute myocardial infarction. Heart84:164-1705, 2000.
8.
de Lemos JA, Antman E, Giugliano R, et al: for the InTIME-II Investigators. Comparison of a 60-versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. Am J Cardiol86:1235-1237, 2000.
9.
Ito H, Tomooka T, Sakai N, et al: Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation85:1699-1705, 1992.
10.
Grant P: The Edinburgh Artery Study: Is lytic activity bad for the heart? Eur Heart J21:1566-1567, 2000.
11.
Shaw J, Jaye PF, Chin-Dusting KB, et al: Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation13:806-812, 2001.
12.
Goldhammer E, Kharash L, Abinader E: Circadian fluctuations in efficacy of streptokinase thrombolysis. Harefuah136:434-437, 1999.
13.
Kharash LM, Goldkhammer EI: Thrombolytic therapy for acute myocardial infarction: Circadian sensitivity. Ter Arkh71:13-17, 1999.
14.
Goldhammer E, Kharash L, Abinader E: Circadian fluctuations in efficacy of streptokinase thrombolysis. Harefuah136:434-437, 1999.
15.
Kurnik PB: Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation91:1341-1346, 1995.
16.
el-Tamimi H, Mansour M, Pepine CJ, et al: Circadian variation in coronary tone in patients with stable angina. Protective role of endothelium. Circulation92:3201-3205, 1995.
17.
Lip G, Blann A: Thrombogenesis and fibrinolysis in acute coronary syndromes. J Am Coll Cardiol36:2044-2046, 2000.
18.
Willich SN, Klatt S, Arntz HR: Circadian variation and triggers of acute coronary syndromes. Eur Heart J19(suppl C):C12-C23, 1998.
19.
Carson P, O’Connor M, Miller A, et al: Circadian rhythm and sudden death in heart failure. J Am Coll Cardiol36:541-546, 2000.
20.
Sutton A, Campbell P, Price D, et al: Failure of thrombolysis by streptokinase: Detection with simple electrocardiographic method. Heart84:149-156, 2000.
